These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1189590)

  • 21. [Blood coagulation studies before and after sclerosing of varicose veins].
    Wuppermann T
    Zentralbl Phlebol; 1971; 10(3):162-9. PubMed ID: 5093626
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose- and time-dependent liquid sclerosant effects on endothelial cell death.
    Kobayashi S; Crooks S; Eckmann DM
    Dermatol Surg; 2006 Dec; 32(12):1444-52. PubMed ID: 17199651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a sclerosing agent (1% polidocanol) to treat an orbital mucocele in a dog.
    Stuckey JA; Miller WW; Almond GT
    Vet Ophthalmol; 2012 May; 15(3):188-93. PubMed ID: 22050766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coagulation level in sclerosing treatment of esophageal varices].
    Brunner G
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1554. PubMed ID: 3652958
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of some benzodiazepine derivatives on blood coagulation in rats.
    Neumann E; Horak J; Cuparencu B; Cucuianu M; Seusan E
    Agressologie; 1978; 19(3):201-9. PubMed ID: 736219
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemical sclerosis of the gallbladder. An experimental study in pigs of the effect of absolute ethanol and polidocanol on gallbladder epithelium.
    Uchiyama N; Stridbeck H; Stenram U
    Acta Radiol; 1989; 30(4):427-31. PubMed ID: 2775604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of varicose veins of the lower extremities with phlebosclerosing preparations].
    Liul'ka AN; Pereĭma FA
    Khirurgiia (Mosk); 1980 Apr; (4):88-91. PubMed ID: 7374089
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the effect of sclerosing agents on the endothelia].
    Gottlob R; Schlobies M
    Med Welt; 1966 May; 22():1225-7. PubMed ID: 5984499
    [No Abstract]   [Full Text] [Related]  

  • 29. [STUDY OF CHANGES IN BLOOD COAGULATION IN THE COURSE OF MASSIVE SCLEROSING TREATMENTS].
    DOMART A; HODARA M; SAMAMA M; TESLER L
    Phlebologie; 1965; 18():73-7. PubMed ID: 14287545
    [No Abstract]   [Full Text] [Related]  

  • 30. [A comparative study on the blood vessel sclerosing effect of pingyungmycin and Natrii morrhuates].
    Zhao J; Zhao Y; Chen X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):97-8, 140. PubMed ID: 11480044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental data on new and known sclerosing solutions].
    Imhoff E
    Zentralbl Phlebol; 1968 Feb; 7(1):99-104. PubMed ID: 5682820
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukocyte activation and leukocyte procoagulant activities after blood contact with polystyrene and polyethylene glycol-immobilized polystyrene beads.
    Gorbet MB; Sefton MV
    J Lab Clin Med; 2001 May; 137(5):345-55. PubMed ID: 11329532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diarrhea, castor oil, and sodium ricinoleate: their effect on electric slow waves of the colon.
    Christensen J; Weisbrodt NW; Hauser RL
    J Lab Clin Med; 1971 Nov; 78(5):828. PubMed ID: 5128873
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of argon plasma coagulation and paravariceal injection sclerotherapy with 1% polidocanol in mucosa-fibrosing therapy for esophageal varices.
    Matsui S; Kudo M; Nakaoka R; Shiomi M; Kawasaki T
    J Gastroenterol; 2004; 39(4):397-9. PubMed ID: 15168254
    [No Abstract]   [Full Text] [Related]  

  • 35. [Secondary esophageal perforation following sclerosing of varices--healing with conservative therapy].
    Jaspersen D
    Med Klin (Munich); 1990 Oct; 85(10):622-3. PubMed ID: 2233594
    [No Abstract]   [Full Text] [Related]  

  • 36. [Aethoxysterol].
    Lakartidningen; 1995 Dec; 92(51-52):4914-6. PubMed ID: 8544517
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of a sclerosing agent on odontogenesis.
    Mehlisch DR; Tolman DE
    Oral Surg Oral Med Oral Pathol; 1971 May; 31(5):723-30. PubMed ID: 4995488
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of tooth development with a sclerosing agent, sodium tetradecyl sulfate.
    Selinger LR; Archer WH; Thonard JC
    J Dent Res; 1966; 45(2):236-42. PubMed ID: 5220215
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart failure as a side effect of polidocanol given for oesophageal variceal sclerosis.
    Imperiali G; Terruzzi V; Spotti D; Minoli G
    Endoscopy; 1986 Sep; 18(5):207. PubMed ID: 3780593
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anaphylaxis following administration of polidocanol].
    Klein Rouweler BJ
    Ned Tijdschr Geneeskd; 1990 Mar; 134(11):553. PubMed ID: 2320151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.